University of Oxford’s Daniel Prieto-Alhambra in a recent interview with The Evidence Base discussed the role of real-world evidence amid the COVID-19 pandemic.
During the interview, he also highlighted a recent virtual “study-a-thon” hosted by the Observational Health Data Sciences and Informatics community.
There are three areas where RWE will shine, he said:
- characterizing COVID-19 patient symptoms, care needs and outcomes to plan care delivery;
- predicting who is most at risk of hospital admission and of poor outcomes, so that we can target and inform management; and
- rapidly and accurately studying the safety profile of potential drug targets, as well as, in the short term, assessing their real-world effectiveness once data are available.
To read the full discussion, click here.